Abstract
Secondary myelodysplastic syndrome (MDS) with t(9;11)(p22;q23) developed in a child after intensive treatment for B-cell acute lymphoblastic leukemia di-agnosed 12 months earlier. His chemotherapy had consisted mainly of cyclo-phosphamide and methotrexate, but no epipodophyllotoxins. The combination of MDS, the cytogenetic anomaly involving bands at 11 q23 and no previous exposure to epipodophyllotoxins represents a unique case of therapy- related leukemia.
Original language | English |
---|---|
Pages (from-to) | 33-35 |
Number of pages | 3 |
Journal | Acta Haematologica |
Volume | 92 |
Issue number | 1 |
DOIs | |
State | Published - 1994 |
Externally published | Yes |
Keywords
- Epipodophyllotoxin
- Myelodysplastic syndrome
- Therapy-related leukemia
- t(9;11)(p22;q23)